Physician profile
John Adrian Lancon
NPI 1013008242
$2,923.41
in general payments reported to CMS, 2019-2025
27 companies · $326 in 2025
The $326 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $544 · 2020: $49.97 · 2021: $1,169 · 2022: $367 · 2023: $160 · 2024: $308 · 2025: $326.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $794.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $793.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,296.85 | 2019-2024 | Mild Device Kit, Es2 Spinal System, Tritanium |
| Gt Medical Technologies, INC | $274.46 | 2021-2025 | Gammatile |
| Providence Medical Technology, INC. | $229.88 | 2022-2025 | |
| Medtronic, INC. | $144.44 | 2023-2025 | Mazor X System, Kyphon Express II Kyphopak Tray, Intellis Adaptivestim |
| Irras USA, INC. | $143.08 | 2019 | |
| Radius Health, INC. | $125.13 | 2019-2022 | |
| Si-Bone, INC. | $103.57 | 2019-2023 | |
| Amgen INC. | $70.56 | 2023-2025 | Evenity, Prolia |
| Innovation Technologies INC | $53.49 | 2024-2025 | Irrisept |
| Portola Pharmaceuticals, LLC | $50.05 | 2019 | |
| Abbott Laboratories | $47.30 | 2025 | Proclaim, Eterna |
| Boston Scientific Corporation | $45.73 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Davol INC. | $37.06 | 2021-2024 | Channel Drain |
| Arteriocyte Medical Systems, INC. | $34.13 | 2024 | Magellan |
| Integra Lifesciences Corporation | $28.85 | 2021-2024 | Duraseal Exact Spinal Sealant System, Cusa Clarity, Codman Certas |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cerapedics INC. | $27.08 | 2022 | |
| Nevro Corp. | $26.35 | 2019 | |
| Medtronic USA, INC. | $22.53 | 2019 | |
| Wound Management Technologies, INC | $21.00 | 2019 | |
| Penumbra, INC. | $20.54 | 2019 | |
| Depuy Synthes Sales INC. | $20.31 | 2020 | |
| Kerecis Limited | $20.16 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Piramal Critical Care | $18.00 | 2019 | |
| Solventum Corporation | $16.58 | 2024 | Prevena |
| Sanara Medtech INC. | $16.09 | 2023 | Celleraterx |
| Kls-Martin L.P. | $15.64 | 2020 | |
| Smith+Nephew, INC. | $14.55 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Lancon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.